Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Observational Study in Localized Osteosarcoma

Multicenter Observational Study on the Treatment of Patients With Localized Osteosarcoma

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Observational prospective trial aimed to collect the collect demographic, clinical, surgical, pathological and molecular characteristics and treatment from patients affected by localized OsteoSarcoma (OS) treated according the AIEOP/Italian Sarcoma Group (ISG) OS 2021

Who May Be Eligible (Plain English)

Who May Qualify: - Diagnosis of high grade OS of the extremities - Age at diagnosis ≤ 40 years at the time of diagnosis - Localized disease (skip metastases are allowed) - your organs (liver, kidneys, etc.) are working well enough based on blood tests according the AIEOP/ISG OS 2021 recommendation - Patients or parents oe guardians of minors who have given their written willing to sign a consent form to participate in the study Who Should NOT Join This Trial: - Presence of metastases - Diagnosis of periosteal OS, of parosteal OS or secondary OS - Any medical condition which can not allowed the use of the treatments recommended by AIEOP/ISG OS 2021 Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Diagnosis of high grade OS of the extremities * Age at diagnosis ≤ 40 years at the time of diagnosis * Localized disease (skip metastases are allowed) * Adequate organ function according the AIEOP/ISG OS 2021 recommendation * Patients or parents oe guardians of minors who have given their written informed consent to participate in the study Exclusion Criteria: * Presence of metastases * Diagnosis of periosteal OS, of parosteal OS or secondary OS * Any medical condition which can not allowed the use of the treatments recommended by AIEOP/ISG OS 2021

Treatments Being Tested

OTHER

Treatment of Osteosarcoma according the AIEOP/ISG OS 2021 recommendations (includes drugs, surgery, radiotherapy or any other received treatments)

This observational study collects all the treatments received by the patients according according the AIEOP/ISG OS 2021 and therefore includes drug/biological/surgical/ radiotherapy and any other applicable treatments

Locations (16)

Centro di Riferimento Oncologico - Unit of Medical Oncology
Aviano, Pordenone, Italy
Sandra Aliberti
Candiolo, Torino, Italy
IRCCS materno infantile Burlo Garofolo
Trieste, T, Italy
Azienda Ospedaliero Universitaria Consorziale Policlinico - Bari
Bari, Italy
IRCCS Istituto ortopedico Rizzoli
Bologna, Italy
A.O. Universitaria Policlinico S. Orsola Malpighi di Bologna
Bologna, Italy
AUO Policnico G. Rodolico San Marco
Catania, Italy
A.O. Universitaria Meyer
Florence, Italy
Istituto Giannina Gaslini
Genova, Italy
Fondazione IRCCS INT Milano SC Pediatria Oncologica
Milan, Italy
FONDAZIONE IRCCS Istituto Nazionale dei Tumori
Milan, Italy
Azienda Ospedaliera di Padova UOC Oncoematologia Pediatrica
Padova, Italy
ARNAS P. O. "Civico e Benfratelli"
Palermo, Italy
Azienda Ospedaliero-Universitaria Pisana
Pisa, Italy
Istituti Fisioterapici Ospitalieri di Roma
Roma, Italy
Ospedale Pediatrico Bambin Gesu'
Roma, Italy